| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977174 | Brachytherapy | 2011 | 6 Pages |
Abstract
MSB is capable of providing target coverage to the cervix, uterus, and paracervical regions equivalent to that provided by HDR 192Ir, while significantly reducing the overall dose to the bladder, rectum, and bowel. This reduction is associated with small regions of increased dose in a significant proportion of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
David M. Cohen, Jessica R. Hiatt, Brigid O'Connor, Bruce Curran, Edward S. Sternick, David E. Wazer,